Register Cart 0

Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back Subscribe

Editorial

Editorial (Thematic Issue: Embryonic Signaling Pathways as Potential Targets for the Treatment of Rhabdomyosarcoma)

Author(s): Soledad Gallego and Josep Roma

Volume 17, Issue 11, 2016

Page: [1226 - 1227] Pages: 2

DOI: 10.2174/1389450117999160304150144

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

32

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

A Dilemma of Functional Genomics: Count the Chickens or Study their Eggs ?
Current Genomics

MicroRNAs in Renal Cell Carcinoma
MicroRNA

PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets

The Functions of Histone Modification Enzymes in Cancer
Current Protein & Peptide Science

Natural Products as Anticancer Agents
Current Drug Targets

Targeting MET Receptor in Rhabdomyosarcoma: Rationale and Progress
Current Drug Targets

Targeting Cancer Stem Cell Lines as a New Treatment of Human Cancer
Recent Patents on Anti-Cancer Drug Discovery

Cyclodepsipeptides - Potential Drugs and Lead Compounds in the Drug Development Process
Current Medicinal Chemistry

MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Current Drug Targets

FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Current Diabetes Reviews

Roles of Nicotinic Acetylcholine Receptors in Stem Cell Survival/Apoptosis, Proliferation and Differentiation
Current Molecular Medicine

The Role of Growth Factors in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neurotoxicity
Current Drug Safety

Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Current Pharmaceutical Design

Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
Current Medicinal Chemistry

Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Anti-Cancer Agents in Medicinal Chemistry

Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Current Medicinal Chemistry

Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer
Current Topics in Medicinal Chemistry

Classification of Sarcomas Using Bioinformatics and Molecular Profiling
Current Pharmaceutical Biotechnology

The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide
Current Cancer Drug Targets

Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function
Endocrine, Metabolic & Immune Disorders - Drug Targets

© 2025 Bentham Science Publishers | Privacy Policy